InVivoMAb anti-mouse VEGFR-2, 25 mg and 3 more items

The University of Virginia awarded a contract to Bio X Cell on September 16, 2026, for the procurement of monoclonal antibodies and control reagents. The contract, designated A207_PO-0480880, carries a cumulative value of $6,228.95 and is being delivered to Ji Song at the University of Virginia in Virginia. The four line items include InVivoMAb anti-mouse vascular endothelial growth factor receptor 2 (VEGFR-2), InVivoMAb anti-mouse programmed cell death protein 1 (PD-1/CD279), and corresponding isotype control reagents (rat immunoglobulin G1 and rat immunoglobulin G2a), each in 25-milligram quantities.

The award consists of four separate deliverables with individual unit prices ranging from $1,528.10 to $1,644.65 per item. All materials are classified as research reagents commonly utilized in immunological and oncological research applications. The contract represents a straightforward procurement of laboratory supplies by an academic institution from a specialized life sciences supplier.